100 mg/ml
Trade Name
Sugammadex Kabi
Solution for injection
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.